Health Canada
- Status: approved
🇨🇦 Intralipid, 20% Intravenous in Canada
Intralipid, 20% Intravenous (Intralipid, 20% Intravenous) regulatory status in Canada.
Marketing authorisation
Intralipid, 20% Intravenous in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Intralipid, 20% Intravenous approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Intralipid, 20% Intravenous in Canada?
Hospital for Special Surgery, New York is the originator. The local marketing authorisation holder may differ — check the official source linked above.